These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of the Effectiveness of Various Medicines in the Prevention of Ovarian Hyperstimulation Syndrome: A Network Meta-Analysis of Randomized Controlled Trials. Wu D; Shi H; Yu Y; Yu T; Zhai J Front Endocrinol (Lausanne); 2022; 13():808517. PubMed ID: 35154015 [TBL] [Abstract][Full Text] [Related]
10. Administration of intravenous albumin around the time of oocyte retrieval reduces pregnancy rate without preventing ovarian hyperstimulation syndrome: a systematic review and meta-analysis. Jee BC; Suh CS; Kim YB; Kim SH; Choi YM; Kim JG; Moon SY Gynecol Obstet Invest; 2010; 70(1):47-54. PubMed ID: 20173327 [TBL] [Abstract][Full Text] [Related]
11. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome. Aboulghar M; Evers JH; Al-Inany H Cochrane Database Syst Rev; 2002; (2):CD001302. PubMed ID: 12076404 [TBL] [Abstract][Full Text] [Related]
12. Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study. Fouda UM; Elshaer HS; Youssef GG; Hanafy A; Mehrem WM; Youssef MA; Farouk M; Nabil H J Obstet Gynaecol; 2022 Jan; 42(1):122-126. PubMed ID: 34270379 [TBL] [Abstract][Full Text] [Related]
13. Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence. Palomba S; Costanzi F; Nelson SM; Caserta D; Humaidan P Reprod Biol Endocrinol; 2023 Jul; 21(1):67. PubMed ID: 37480081 [TBL] [Abstract][Full Text] [Related]
14. Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials. Leitao VM; Moroni RM; Seko LM; Nastri CO; Martins WP Fertil Steril; 2014 Mar; 101(3):664-75. PubMed ID: 24360566 [TBL] [Abstract][Full Text] [Related]
15. Prevention of ovarian hyperstimulation syndrome in GnRH agonist IVF cycles in moderate risk patients: randomized study comparing hydroxyethyl starch versus cabergoline and hydroxyethyl starch. Matorras R; Andrés M; Mendoza R; Prieto B; Pijoan JI; Expósito A Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):439-43. PubMed ID: 23932181 [TBL] [Abstract][Full Text] [Related]
16. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome. Aboulghar M; Evers JH; Al-Inany H Cochrane Database Syst Rev; 2000; (2):CD001302. PubMed ID: 10796765 [TBL] [Abstract][Full Text] [Related]
17. Calcium gluconate infusion is not as effective as dopamine agonists in preventing ovarian hyperstimulation syndrome. Turktekin N; Karakus C; Ozyurt R Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1248-1254. PubMed ID: 35253181 [TBL] [Abstract][Full Text] [Related]
19. Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis. Bosdou JK; Venetis CA; Tarlatzis BC; Grimbizis GF; Kolibianakis EM Hum Reprod; 2019 Mar; 34(3):491-505. PubMed ID: 30689865 [TBL] [Abstract][Full Text] [Related]
20. Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation. Kamath MS; Maheshwari A; Bhattacharya S; Lor KY; Gibreel A Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008528. PubMed ID: 29096046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]